Menu
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
Google and Macy's were among several stocks powering the Dow Jones and S&P 500 to fresh record closes on Wednesday. More
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
Defensive stocks have been on fire and outpacing the broader market for months. However, while many still offer enticing yields, you'll be overpaying by jumping in now. More
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
Researchers at biotechnology firm Amgen are studying how skin reacts to chili pepper oil to help develop new drugs for migranes. More
Sponsored By:
Sponsored By:
